Lipidomics Standards Initiative (LSI) was initiated 2018 by Kim Ekroos and Gerhard Liebisch. Both are currently coordinating efforts to develop guidelines for Lipidomics.

Current members

  • Robert Ahrends, Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna, Austria
  • Masanori Arita, RIKEN Center for Sustainable Resource Science, Yokohama, Japan, National Institute of Genetics, Mishima, Japan
  • Takeshi Bamba, Division of Metabolomics, Medical Institute of Bioregulation, Kyushu University, Japan
  • Steffany Bennett, India Taylor Lipidomics Research Platform, University of Ottawa, Ottawa, Canada
  • Justine Bertand-Michel, MetaToul-Lipidomic MetaboHUB Core Facility, Inserm, Toulouse, France
  • Stephen Blanksby, Central Analytical Research Facility, Institute for Future Environments, Queensland University of Technology, Brisbane, Australia
  • John Bowden, Chemical Sciences Division, Hollings Marine Laboratory, National Institute of Standards and Technology, Charleston, USA
  • Ralph Burkhardt, Institute of Clinical Chemistry and Laboratory Medicine, University of Regensburg, Germany
  • Christer Ejsing, Department of Biochemistry and Molecular Biology, VILLUM Center for Bioanalytical Sciences, University of Southern Denmark, Odense, Denmark
  • Kim Ekroos, Lipidomics Consulting Ltd., Esbo, Finland
  • Shane Ellis, M4I Institute, The Maastricht Multimodal Molecular Imaging Institute, Maastricht University, The Netherlands
  • Maria Fedorova, Institute of Bioanalytical Chemistry, Faculty of Chemistry and Mineralogy, University of Leipzig, Germany
  • Bill Griffiths, Swansea University Medical School, Swansea, UK
  • Xianlin Han, Center for Metabolic Origins of Disease, Sanford Burnham Prebys Medical Discovery Institute, Orlando, USA
  • Michal Holčapek, Department of Analytical Chemistry, Faculty of Chemical Technology, University of Pardubice, Czech Republic
  • Harald Köfeler, Core Facility for Mass Spectrometry and Lipidomics, Medical University of Graz, Austria
  • Jeff McDonald, Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, USA
  • Gerhard Liebisch, Institute of Clinical Chemistry and Laboratory Medicine, University of Regensburg, Germany
  • Arita Makoto, Laboratory for Metabolomics, RIKEN Center for Integrative Medical Sciences (IMS), Tsurumi, Yokohama, Japan
  • Todd Mitchell, School of Medicine, Illawarra Health and Medical Research Institute, University of Wollongong, Australia
  • Valerie O’Donnell, Systems Immunity Research Institute and Division of Infection and Immunity, School of Medicine, Cardiff University, UK
  • Gavin Reid, Department of Biochemistry and Molecular Biology, University of Melbourne, Australia
  • Dominik Schwudke, Division of Bioanalytical Chemistry, Research Center Borstel, Germany
  • Andrej Shevchenko, MPI of Molecular Cell Biology and Genetics , Dresden, Germany
  • Michael Wakelam, Babraham Institute, Cambridge, UK
  • Markus Wenk, Singapore Lipidomics Incubator (SLING), Department of Biochemistry, YLL School of Medicine, National University of Singapore
  • Dayanjan Wijesinghe, School of Pharmacy, Virginia Commonwealth University, Richmond, USA


LSI serves as a communication platform for discussion and further development of lipidomics standards. Anyone can directly communicate with the LSI community through our discussion board. Please generate your personal account and contribute to existing discussions or post a new topic.